Skip to content

Modifiers in PMP22 related neuropathies

Modifiers in PMP22 related neuropathies - Modifiers in PMP22 related neuropathies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32269
Enrollment
1080
Registered
2008-10-21
Start date
2009-08-24
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Charcot-Marie-Tooth disease Hereditary Motor and Sensory Neuropathy

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
12 Years to 99 Years

Inclusion criteria

Inclusion criteria: duplication or deletion of PMP22-gene, age 12-60 year

Exclusion criteria

Exclusion criteria: - Use of medication or suffering from other disease than CMT/HNPP that can cause neuropathy - comorbidity interfering with mobility - non-Caucasian patients

Design outcomes

Primary

MeasureTime frame
The presence or absence of copy number variants (CNV) and sequence variants of CMT genes and genes involved in the immune system between the most severely and mildest affected patients.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)